University of Minnesota discovery is now a first-in-human clinical trial for leukemia
The discovery of tri-specific natural killer engagers (TriKE), a combination protein that bridges an immune cell and a tumor cell to drive tumor cell killing power exponentially, has led to a new Phase I, first-in-human study ...
Sep 19, 2019